Furthermore, one study described an overrepresentation of rare mutations in DROSHA, a key enzyme involved in miRNA processing, among clinically diagnosed HHT patients who did not carry any mutations in the typical HHT-associated genes (20). Here, DROSHA is linked to hereditary hemorrhagic telangiectasia.